ArticleJournal of experimental & clinical cancer research : CR2022

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.

Zijie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.